Net profit of Welcure Drugs & Pharmaceuticals rose 361.96% to Rs 8.50 crore in the quarter ended September 2025 as against Rs 1.84 crore during the previous quarter ended September 2024. Sales rose 167.29% to Rs 65.62 crore in the quarter ended September 2025 as against Rs 24.55 crore during the previous quarter ended September 2024.
| Particulars | Quarter Ended |
| Sep. 2025 | Sep. 2024 | % Var. |
| Sales | 65.62 | 24.55 | 167 |
| OPM % | 17.31 | 7.54 | - |
| PBDT | 11.36 | 1.85 | 514 |
| PBT | 11.36 | 1.84 | 517 |
| NP | 8.50 | 1.84 | 362 |